Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | Justera Health Ltd: Justera to be late to file 2023 results | 1 | Stockwatch | ||
Mo | Justera Health Ltd.: Justera Addresses Delay on Annual Filings | 223 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 29, 2024) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") regrettably announces that it has not met the deadline for filing... ► Artikel lesen | |
Fr | Justera Health Ltd: Justera Health director Burpee resigns | 1 | Stockwatch | ||
Fr | Justera Health Ltd.: Justera Announces Changes to Management | 611 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 26, 2024) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") today announces the resignation of Tyler Burpee from its board for... ► Artikel lesen | |
22.03. | Justera Health Ltd: Justera Health appoints Burpee as a director | 1 | Stockwatch | ||
22.03. | Justera Health Ltd.: Justera Appoints New Director | 659 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 22, 2024) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") announces the appointment of Tyler Burpee to the board of directors... ► Artikel lesen | |
21.12.23 | Justera Health Ltd: Justera's Naturevan fulfills $103K Costco Korea order | 5 | Stockwatch | ||
21.12.23 | Justera Health Ltd.: Naturevan Fulfills $103K P.O. and Receives Full Payment | 304 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 21, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") is pleased to announce that subsequent to the news release dated... ► Artikel lesen | |
13.12.23 | Justera Health Ltd: Justera Health rolls out on-line K-beauty store | 2 | Stockwatch | ||
13.12.23 | Justera Health Ltd.: Justera Introduces K-Beauty Online Store | 290 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 13, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") is pleased to introduce its K-beauty online store(https://tonymoly.ca/)... ► Artikel lesen | |
12.12.23 | Justera Health Ltd: Justera Health appoints Lee as CEO | 1 | Stockwatch | ||
12.12.23 | Justera Health Ltd.: Justera Announces Changes to Management | 551 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 12, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") is pleased to announce changes to its management. Young Cho Lee... ► Artikel lesen | |
07.12.23 | Justera Health Ltd.: Justera Announces 2023 AGM Results | 362 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 7, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") announces the voting results from the Annual General and Special... ► Artikel lesen | |
23.11.23 | Justera Health Ltd.: Justera Secures Supply Agreement for Emart24 to Expand Global Reach | 792 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 23, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") is pleased to announce that its wholly-owned subsidiary, Naturevan... ► Artikel lesen | |
20.11.23 | Justera Health Ltd: Justera boasts about Juillet revenue with Cutera XEO | 8 | Stockwatch | ||
20.11.23 | Justera Health Ltd.: Justera Revenue Boosts with Launching of Cutera XEO Laser Treatment and Plan to Expand | 504 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 20, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") is pleased to announce that the Company's wholly-owned subsidiary... ► Artikel lesen | |
15.11.23 | Justera Health Ltd: Justera Health completes Triniti acquisition | 2 | Stockwatch | ||
15.11.23 | Justera Health Ltd.: Justera Completes Acquisition of K-Beauty Company, Triniti Trading Corp. | 433 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 15, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") is pleased to announce it has completed the previously announced... ► Artikel lesen | |
14.11.23 | Justera Health Ltd: Justera's Naturevan to supply products to Coupang | 10 | Stockwatch | ||
14.11.23 | Justera Health Ltd.: Justera Announces Supply Agreement for Coupang | 671 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 14, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") is pleased to announce that its wholly-owned subsidiary, Naturevan... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PROCEPT BIOROBOTICS | 60,61 | 0,00 % | Earnings call: PROCEPT BioRobotics sees 83% revenue surge in Q1 2024 | ||
FRESENIUS | 28,230 | +0,93 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Fresenius vor Quartalszahlen von 41 auf 40 Euro gesenkt und die Einstufung auf "Buy" belassen. Ein zunächst vorsichtiger... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 51,34 | -1,46 % | EQS-DD: Siemens Healthineers AG: Dr. Bernhard Montag, Kauf von Siemens Healthineers Aktien für einen Betrag von EUR 98.817,91 abzüglich Steuern und Abgaben als automatische Wiederanlage von ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
26.04.2024 / 14:49... ► Artikel lesen | |
ATRICURE | 24,810 | 0,00 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
GENEDX | 20,880 | 0,00 % | Pre-market Movers: Cyclacel Pharmaceuticals, Marin Software, GeneDx, Sensata Technologies, Lichen China | INDIANAPOLIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.05 A.M. ET).In the Green Cyclacel Pharmaceuticals, Inc. (CYCC) is up... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 40,170 | +1,44 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für FMC vor Quartalszahlen von 29 auf 32 Euro angehoben und die Einstufung auf "Underperform" belassen. Nachdem sich der Dialysespezialist... ► Artikel lesen | |
ADAPTHEALTH | 10,060 | 0,00 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
RXSIGHT | 56,73 | 0,00 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
MIMEDX | 7,300 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 18,000 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
CARL ZEISS MEDITEC | 98,00 | -1,11 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
DOCGO | 3,390 | 0,00 % | Evaluating DocGo: Insights From 8 Financial Analysts | ||
GERRESHEIMER | 101,30 | +0,30 % | Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen | Düsseldorf/Berlin/Ohio, USA (ots) - Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen- Gerresheimer-Tochter Centor erhält exklusive Vertriebsrechte für Apotheken in den USA-... ► Artikel lesen | |
CASTLE BIOSCIENCES | 22,060 | 0,00 % | Castle Biosciences Inc.: Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | If choosing to use a molecular test to rule-out a sentinel lymph node biopsy (SLNB) in patients diagnosed with melanoma, it is important to show that patients foregoing an SLNB have low risk outcomes... ► Artikel lesen |